Trials / Completed
CompletedNCT02191462
A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects
A Randomized, Double-blind, Cross-over Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study in to analyse the way in which the body processes Niagen (nicotinamide riboside) in healthy people. Blood and urine samples from subjects who are given a dose of Niagen will be analyzed for metabolites over the 24 hours after taking the dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Niagen 100mg | |
| DIETARY_SUPPLEMENT | Niagen 300mg | |
| DIETARY_SUPPLEMENT | Niagen 1000mg |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-07-16
- Last updated
- 2014-09-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02191462. Inclusion in this directory is not an endorsement.